NCT03168841View on ClinicalTrials.gov

Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 6, 2017

Primary Completion Date

January 9, 2019

Study Completion Date

January 9, 2019

Conditions
Onychomycosis
Interventions
DRUG

Efinaconazole Topical

Enrolled subjects will be dispensed medical for topical application, and followed for a period of 50 weeks.

Trial Locations (1)

91711

Western University of Health Sciences, Pomona

All Listed Sponsors
lead

Western University of Health Sciences

OTHER

NCT03168841 - Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients | Biotech Hunter | Biotech Hunter